Latest Food & Drug Administration news
FDA Sends Warning Letters to Companies Selling Illegal Opioid Compound
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Kerendia Approved for Heart Failure With Left Ventricular Ejection Fraction ≥40 Percent
posted July 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma
posted June 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Offers Speedier Approvals to Drug Companies Aligning With “National Priorities”
posted June 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications
Editor's Recommendations
2008 to 2020 Saw Increase in Cost of Medical School Attendance 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
2022 No Surprises Act Reduced Patient Out-of-Pocket Spending 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
